Literature DB >> 29700813

The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial.

Chris Hollis1, Charlotte L Hall1, Boliang Guo1, Marilyn James2, Janet Boadu2, Madeleine J Groom1, Nikki Brown1, Catherine Kaylor-Hughes1, Maria Moldavsky3, Althea Z Valentine1, Gemma M Walker1, David Daley1, Kapil Sayal1, Richard Morriss1.   

Abstract

BACKGROUND: Diagnosis of attention deficit hyperactivity disorder (ADHD) relies on subjective methods which can lead to diagnostic uncertainty and delay. This trial evaluated the impact of providing a computerised test of attention and activity (QbTest) report on the speed and accuracy of diagnostic decision-making in children with suspected ADHD.
METHODS: Randomised, parallel, single-blind controlled trial in mental health and community paediatric clinics in England. Participants were 6-17 years-old and referred for ADHD diagnostic assessment; all underwent assessment-as-usual, plus QbTest. Participants and their clinician were randomised to either receive the QbTest report immediately (QbOpen group) or the report was withheld (QbBlind group). The primary outcome was number of consultations until a diagnostic decision confirming/excluding ADHD within 6-months from baseline. Health economic cost-effectiveness and cost utility analysis was conducted. Assessing QbTest Utility in ADHD: A Randomised Controlled Trial was registered at ClinicalTrials.gov (https://clinicaltrials.gov/ct2/show/NCT02209116).
RESULTS: One hundred and thirty-two participants were randomised to QbOpen group (123 analysed) and 135 to QbBlind group (127 analysed). Clinicians with access to the QbTest report (QbOpen) were more likely to reach a diagnostic decision about ADHD (hazard ratio 1.44, 95% CI 1.04-2.01). At 6-months, 76% of those with a QbTest report had received a diagnostic decision, compared with 50% without. QbTest reduced appointment length by 15% (time ratio 0.85, 95% CI 0.77-0.93), increased clinicians' confidence in their diagnostic decisions (odds ratio 1.77, 95% CI 1.09-2.89) and doubled the likelihood of excluding ADHD. There was no difference in diagnostic accuracy. Health economic analysis showed a position of strict dominance; however, cost savings were small suggesting that the impact of providing the QbTest report within this trial can best be viewed as 'cost neutral'.
CONCLUSIONS: QbTest may increase the efficiency of ADHD assessment pathway allowing greater patient throughput with clinicians reaching diagnostic decisions faster without compromising diagnostic accuracy.
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Entities:  

Keywords:  QbTest; assessment; attention deficit hyperactivity disorder; continuous performance test

Mesh:

Year:  2018        PMID: 29700813      PMCID: PMC6124643          DOI: 10.1111/jcpp.12921

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  33 in total

1.  Predictive power of frontal lobe tests in the diagnosis of attention deficit hyperactivity disorder.

Authors:  G M Grodzinsky; R A Barkley
Journal:  Clin Neuropsychol       Date:  1999-02       Impact factor: 3.535

2.  CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2010-03-25       Impact factor: 6.437

3.  The incremental validity of a computerised assessment added to clinical rating scales to differentiate adult ADHD from autism spectrum disorder.

Authors:  Madeleine J Groom; Zoe Young; Charlotte L Hall; Alinda Gillott; Chris Hollis
Journal:  Psychiatry Res       Date:  2016-06-25       Impact factor: 3.222

4.  The decisions regarding ADHD management (DRAMa) study: uncertainties and complexities in assessment, diagnosis and treatment, from the clinician's point of view.

Authors:  Hanna Kovshoff; Sarah Williams; May Vrijens; Marina Danckaerts; Margaret Thompson; Lucy Yardley; Paul Hodgkins; Edmund J S Sonuga-Barke
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-12-18       Impact factor: 4.785

5.  The utility of self-report measures and the continuous performance test in the diagnosis of ADHD in adults.

Authors:  Mary V Solanto; Kennett Etefia; David J Marks
Journal:  CNS Spectr       Date:  2004-09       Impact factor: 3.790

6.  Quantitative and subjective behavioural aspects in the assessment of attention-deficit hyperactivity disorder (ADHD) in adults.

Authors:  Staffan Söderström; Richard Pettersson; Kent W Nilsson
Journal:  Nord J Psychiatry       Date:  2013-03-26       Impact factor: 2.202

7.  A children's global assessment scale (CGAS).

Authors:  D Shaffer; M S Gould; J Brasic; P Ambrosini; P Fisher; H Bird; S Aluwahlia
Journal:  Arch Gen Psychiatry       Date:  1983-11

Review 8.  Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects?

Authors:  Brennan C Kahan; Tim P Morris
Journal:  Stat Med       Date:  2012-10-30       Impact factor: 2.373

9.  Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial.

Authors:  Charlotte L Hall; Gemma M Walker; Althea Z Valentine; Boliang Guo; Catherine Kaylor-Hughes; Marilyn James; David Daley; Kapil Sayal; Chris Hollis
Journal:  BMJ Open       Date:  2014-12-01       Impact factor: 2.692

10.  Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey.

Authors:  Moshe Fridman; Tobias Banaschewski; Vanja Sikirica; Javier Quintero; Kristina S Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-30       Impact factor: 2.570

View more
  13 in total

1.  Consensus workshops on the development of an ADHD medication management protocol using QbTest: developing a clinical trial protocol with multidisciplinary stakeholders.

Authors:  Charlotte L Hall; Susan Brown; Marilyn James; Jennifer L Martin; Nikki Brown; Kim Selby; Julie Clarke; Laura Williams; Kapil Sayal; Chris Hollis; Madeleine J Groom
Journal:  BMC Med Res Methodol       Date:  2019-06-18       Impact factor: 4.615

Review 2.  Toward Precision Medicine in ADHD.

Authors:  Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski
Journal:  Front Behav Neurosci       Date:  2022-07-06       Impact factor: 3.617

Review 3.  ADHD in Children and Adults: Diagnosis and Prognosis.

Authors:  Douglas Teixeira Leffa; Arthur Caye; Luis Augusto Rohde
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Associations of the Behavioral Assessment and Research System (BARS) neurobehavioral outcomes with attention problems in children living near coal ash storage sites.

Authors:  Lonnie Sears; Clara G Sears; John V Myers; Guy N Brock; Kristina M Zierold
Journal:  Neurotoxicology       Date:  2020-08-15       Impact factor: 4.294

5.  Predicting ADHD symptoms and diagnosis at age 14 from objective activity levels at age 7 in a large UK cohort.

Authors:  Valerie Brandt; Praveetha Patalay; Julia Kerner Auch Koerner
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-06-06       Impact factor: 4.785

6.  Objective measurement of attention deficit hyperactivity disorder symptoms outside the clinic using the QbCheck: Reliability and validity.

Authors:  Fredrik Ulberstad; Hans Boström; Mira-Lynn Chavanon; Martin Knollmann; James Wiley; Hanna Christiansen; Lisa B Thorell
Journal:  Int J Methods Psychiatr Res       Date:  2020-02-25       Impact factor: 4.035

Review 7.  Economic evaluations of big data analytics for clinical decision-making: a scoping review.

Authors:  Lytske Bakker; Jos Aarts; Carin Uyl-de Groot; William Redekop
Journal:  J Am Med Inform Assoc       Date:  2020-07-01       Impact factor: 4.497

8.  The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study.

Authors:  Rajna Knez; Dejan Stevanovic; Salmir Nasic; Ana Doric; Elisabet Wentz
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-06       Impact factor: 2.570

9.  Optimising medication management in children and young people with ADHD using a computerised test (QbTest): a feasibility randomised controlled trial.

Authors:  Laura Williams; Charlotte L Hall; Sue Brown; Boliang Guo; Marilyn James; Matilde Franceschini; Julie Clarke; Kim Selby; Hena Vijayan; Neeta Kulkarni; Nikki Brown; Kapil Sayal; Chris Hollis; Madeleine J Groom
Journal:  Pilot Feasibility Stud       Date:  2021-03-16

10.  FACT: a randomised controlled trial to assess the feasibility of QbTest in the assessment process of attention deficit hyperactivity disorder (ADHD) for young people in prison-a feasibility trial protocol.

Authors:  Charlotte Lennox; Charlotte Lucy Hall; Lesley-Anne Carter; Bryony Beresford; Susan Young; Abdullah Kraam; Nikki Brown; Lloyd Wilkinson-Cunningham; Mindy Reeves; Prathiba Chitsabesan
Journal:  BMJ Open       Date:  2020-01-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.